Document Detail


Placental pathology in pregnancies with maternally perceived decreased fetal movement--a population-based nested case-cohort study.
MedLine Citation:
PMID:  22723978     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Decreased fetal movements (DFM) are associated with fetal growth restriction and stillbirth, presumably linked through an underlying placental dysfunction. Yet, the role of placental pathology has received limited attention in DFM studies. Our main objective was to explore whether maternal perceptions of DFM were associated with placental pathology in pregnancies recruited from a low-risk total population.
METHODS/PRINCIPAL FINDINGS: Placentas from 129 DFM and 191 non-DFM pregnancies were examined according to standardized macro- and microscopic protocols. DFM was defined as any maternal complaint of DFM leading to a hospital examination. Morphological findings were timed and graded according to their estimated onset and clinical importance, and classified in line with a newly constructed Norwegian classification system for reporting placental pathology. With our population-based approach we were unable to link DFM to an overall measure of all forms of placental pathology (OR 1.3, 95% CI 0.8-2.2, p = 0.249). However, placental pathology leading to imminent delivery could be a competing risk for DFM, making separate subgroup analyses more appropriate. Our study suggests a link between DFM and macroscopic placental pathology related to maternal, uteroplacental vessels, i.e. infarctions, placental lesions (intraplacental hematomas) and abruptions. Although not statistically significant separately, a compound measure showed a significant association with DFM (OR 2.4, 95%CI 1.1-5.0, p = 0.023). This association was strengthened when we accounted for relevant temporal aspects. More subtle microscopic materno-placental ischemic changes outside the areas of localized pathology showed no association with DFM (OR 0.5, 95%CI 0.2-1.4, p = 0.203). There was a strong association between placental pathology and neonatal complications (OR 2.9, 95% CI 1.6-5.1, p<0.001).
CONCLUSIONS: In our population-based study we were generally unable to link maternally perceived DFM to placental pathology. Some associations were seen for subgroups.
Authors:
Brita Askeland Winje; Borghild Roald; Nina Petrov Kristensen; J Frederik Frøen
Related Documents :
15618258 - Factor v leiden mutation in relation to fecundity and miscarriage in women with venous ...
22723978 - Placental pathology in pregnancies with maternally perceived decreased fetal movement--...
10391528 - Anticoagulant therapy in pregnancy.
21845068 - Twin versus singleton pregnancies: the incidence, pregnancy complications, and obstetri...
3544658 - Is the early growth delay in the diabetic pregnancy accompanied by a delay in placental...
19089778 - Pregnancy-associated colon and rectal cancer: perinatal and cancer outcomes.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-06-19
Journal Detail:
Title:  PloS one     Volume:  7     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2012  
Date Detail:
Created Date:  2012-06-22     Completed Date:  2012-12-12     Revised Date:  2013-07-12    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e39259     Citation Subset:  IM    
Affiliation:
Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway. brita.winje@fhi.no
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Case-Control Studies
Female
Fetal Growth Retardation
Fetal Movement*
Humans
Placenta / pathology*
Pregnancy
Pregnancy Complications / pathology
Pregnancy Outcome
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A two-stage model for lipid modulation of the activity of integral membrane proteins.
Next Document:  Interaction of protein C inhibitor with the type II transmembrane serine protease enteropeptidase.